ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intermittent Claudication Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-12P8547
Home | Market Reports | Health| Health Conditions
Global Intermittent Claudication Market Insights Forecast to 2028
BUY CHAPTERS

Global Intermittent Claudication Market Research Report 2025

Code: QYRE-Auto-12P8547
Report
July 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
I'ROM GROUP(DNAVEC Corporation)
Nuo Therapeutics Inc
Kowa Company Ltd
LTT Bio-Pharma
Pluristem Therapeutics Inc
Nuo Therapeutics, Inc.(Aldagen, Inc.)
Genovate Biotechnology Co., Ltd.
Novartis
ID Pharma Co Ltd
Helixmith Co., Ltd.
G.Pohl-Boskamp GmbH＆Co.KG

Intermittent Claudication Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Intermittent Claudication Market

Intermittent Claudication Market

The global market for Intermittent Claudication was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Intermittent claudication is a type of muscle pain especially in calf muscle during exercise, such as walking, and is relieved by a short period of rest due to lack of blood supply.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intermittent Claudication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intermittent Claudication.
The Intermittent Claudication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intermittent Claudication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intermittent Claudication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Intermittent Claudication Market Report

Report Metric Details
Report Name Intermittent Claudication Market
CAGR 5%
Segment by Type
  • by Treatment Process
  • by Drug Type
Segment by Application
  • Hospitals
  • Clinics
  • Home Healthcare
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company I'ROM GROUP(DNAVEC Corporation), Nuo Therapeutics Inc., Kowa Company Ltd., LTT Bio-Pharma, Pluristem Therapeutics Inc., Nuo Therapeutics, Inc.(Aldagen, Inc.), Genovate Biotechnology Co., Ltd., Novartis AG, ID Pharma Co., Ltd, Helixmith Co., Ltd., G. Pohl-Boskamp GmbH & Co. KG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Intermittent Claudication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intermittent Claudication Market report?

Ans: The main players in the Intermittent Claudication Market are I'ROM GROUP(DNAVEC Corporation), Nuo Therapeutics Inc., Kowa Company Ltd., LTT Bio-Pharma, Pluristem Therapeutics Inc., Nuo Therapeutics, Inc.(Aldagen, Inc.), Genovate Biotechnology Co., Ltd., Novartis AG, ID Pharma Co., Ltd, Helixmith Co., Ltd., G. Pohl-Boskamp GmbH & Co. KG

What are the Application segmentation covered in the Intermittent Claudication Market report?

Ans: The Applications covered in the Intermittent Claudication Market report are Hospitals, Clinics, Home Healthcare, Others

What are the Type segmentation covered in the Intermittent Claudication Market report?

Ans: The Types covered in the Intermittent Claudication Market report are by Treatment Process, by Drug Type

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intermittent Claudication Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 by Treatment Process
1.2.3 by Drug Type
1.3 Market by Application
1.3.1 Global Intermittent Claudication Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Healthcare
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intermittent Claudication Market Perspective (2020-2031)
2.2 Global Intermittent Claudication Growth Trends by Region
2.2.1 Global Intermittent Claudication Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Intermittent Claudication Historic Market Size by Region (2020-2025)
2.2.3 Intermittent Claudication Forecasted Market Size by Region (2026-2031)
2.3 Intermittent Claudication Market Dynamics
2.3.1 Intermittent Claudication Industry Trends
2.3.2 Intermittent Claudication Market Drivers
2.3.3 Intermittent Claudication Market Challenges
2.3.4 Intermittent Claudication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intermittent Claudication Players by Revenue
3.1.1 Global Top Intermittent Claudication Players by Revenue (2020-2025)
3.1.2 Global Intermittent Claudication Revenue Market Share by Players (2020-2025)
3.2 Global Intermittent Claudication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Intermittent Claudication Revenue
3.4 Global Intermittent Claudication Market Concentration Ratio
3.4.1 Global Intermittent Claudication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intermittent Claudication Revenue in 2024
3.5 Global Key Players of Intermittent Claudication Head office and Area Served
3.6 Global Key Players of Intermittent Claudication, Product and Application
3.7 Global Key Players of Intermittent Claudication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Intermittent Claudication Breakdown Data by Type
4.1 Global Intermittent Claudication Historic Market Size by Type (2020-2025)
4.2 Global Intermittent Claudication Forecasted Market Size by Type (2026-2031)
5 Intermittent Claudication Breakdown Data by Application
5.1 Global Intermittent Claudication Historic Market Size by Application (2020-2025)
5.2 Global Intermittent Claudication Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Intermittent Claudication Market Size (2020-2031)
6.2 North America Intermittent Claudication Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Intermittent Claudication Market Size by Country (2020-2025)
6.4 North America Intermittent Claudication Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intermittent Claudication Market Size (2020-2031)
7.2 Europe Intermittent Claudication Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Intermittent Claudication Market Size by Country (2020-2025)
7.4 Europe Intermittent Claudication Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intermittent Claudication Market Size (2020-2031)
8.2 Asia-Pacific Intermittent Claudication Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Intermittent Claudication Market Size by Region (2020-2025)
8.4 Asia-Pacific Intermittent Claudication Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intermittent Claudication Market Size (2020-2031)
9.2 Latin America Intermittent Claudication Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Intermittent Claudication Market Size by Country (2020-2025)
9.4 Latin America Intermittent Claudication Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intermittent Claudication Market Size (2020-2031)
10.2 Middle East & Africa Intermittent Claudication Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Intermittent Claudication Market Size by Country (2020-2025)
10.4 Middle East & Africa Intermittent Claudication Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 I'ROM GROUP(DNAVEC Corporation)
11.1.1 I'ROM GROUP(DNAVEC Corporation) Company Details
11.1.2 I'ROM GROUP(DNAVEC Corporation) Business Overview
11.1.3 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Introduction
11.1.4 I'ROM GROUP(DNAVEC Corporation) Revenue in Intermittent Claudication Business (2020-2025)
11.1.5 I'ROM GROUP(DNAVEC Corporation) Recent Development
11.2 Nuo Therapeutics Inc.
11.2.1 Nuo Therapeutics Inc. Company Details
11.2.2 Nuo Therapeutics Inc. Business Overview
11.2.3 Nuo Therapeutics Inc. Intermittent Claudication Introduction
11.2.4 Nuo Therapeutics Inc. Revenue in Intermittent Claudication Business (2020-2025)
11.2.5 Nuo Therapeutics Inc. Recent Development
11.3 Kowa Company Ltd.
11.3.1 Kowa Company Ltd. Company Details
11.3.2 Kowa Company Ltd. Business Overview
11.3.3 Kowa Company Ltd. Intermittent Claudication Introduction
11.3.4 Kowa Company Ltd. Revenue in Intermittent Claudication Business (2020-2025)
11.3.5 Kowa Company Ltd. Recent Development
11.4 LTT Bio-Pharma
11.4.1 LTT Bio-Pharma Company Details
11.4.2 LTT Bio-Pharma Business Overview
11.4.3 LTT Bio-Pharma Intermittent Claudication Introduction
11.4.4 LTT Bio-Pharma Revenue in Intermittent Claudication Business (2020-2025)
11.4.5 LTT Bio-Pharma Recent Development
11.5 Pluristem Therapeutics Inc.
11.5.1 Pluristem Therapeutics Inc. Company Details
11.5.2 Pluristem Therapeutics Inc. Business Overview
11.5.3 Pluristem Therapeutics Inc. Intermittent Claudication Introduction
11.5.4 Pluristem Therapeutics Inc. Revenue in Intermittent Claudication Business (2020-2025)
11.5.5 Pluristem Therapeutics Inc. Recent Development
11.6 Nuo Therapeutics, Inc.(Aldagen, Inc.)
11.6.1 Nuo Therapeutics, Inc.(Aldagen, Inc.) Company Details
11.6.2 Nuo Therapeutics, Inc.(Aldagen, Inc.) Business Overview
11.6.3 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Introduction
11.6.4 Nuo Therapeutics, Inc.(Aldagen, Inc.) Revenue in Intermittent Claudication Business (2020-2025)
11.6.5 Nuo Therapeutics, Inc.(Aldagen, Inc.) Recent Development
11.7 Genovate Biotechnology Co., Ltd.
11.7.1 Genovate Biotechnology Co., Ltd. Company Details
11.7.2 Genovate Biotechnology Co., Ltd. Business Overview
11.7.3 Genovate Biotechnology Co., Ltd. Intermittent Claudication Introduction
11.7.4 Genovate Biotechnology Co., Ltd. Revenue in Intermittent Claudication Business (2020-2025)
11.7.5 Genovate Biotechnology Co., Ltd. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Intermittent Claudication Introduction
11.8.4 Novartis AG Revenue in Intermittent Claudication Business (2020-2025)
11.8.5 Novartis AG Recent Development
11.9 ID Pharma Co., Ltd
11.9.1 ID Pharma Co., Ltd Company Details
11.9.2 ID Pharma Co., Ltd Business Overview
11.9.3 ID Pharma Co., Ltd Intermittent Claudication Introduction
11.9.4 ID Pharma Co., Ltd Revenue in Intermittent Claudication Business (2020-2025)
11.9.5 ID Pharma Co., Ltd Recent Development
11.10 Helixmith Co., Ltd.
11.10.1 Helixmith Co., Ltd. Company Details
11.10.2 Helixmith Co., Ltd. Business Overview
11.10.3 Helixmith Co., Ltd. Intermittent Claudication Introduction
11.10.4 Helixmith Co., Ltd. Revenue in Intermittent Claudication Business (2020-2025)
11.10.5 Helixmith Co., Ltd. Recent Development
11.11 G. Pohl-Boskamp GmbH & Co. KG
11.11.1 G. Pohl-Boskamp GmbH & Co. KG Company Details
11.11.2 G. Pohl-Boskamp GmbH & Co. KG Business Overview
11.11.3 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Introduction
11.11.4 G. Pohl-Boskamp GmbH & Co. KG Revenue in Intermittent Claudication Business (2020-2025)
11.11.5 G. Pohl-Boskamp GmbH & Co. KG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
I'ROM GROUP(DNAVEC Corporation)
Nuo Therapeutics Inc
Kowa Company Ltd
LTT Bio-Pharma
Pluristem Therapeutics Inc
Nuo Therapeutics, Inc.(Aldagen, Inc.)
Genovate Biotechnology Co., Ltd.
Novartis
ID Pharma Co Ltd
Helixmith Co., Ltd.
G.Pohl-Boskamp GmbH＆Co.KG
List of Tables
 Table 1. Global Intermittent Claudication Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of by Treatment Process
 Table 3. Key Players of by Drug Type
 Table 4. Global Intermittent Claudication Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Intermittent Claudication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Intermittent Claudication Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Intermittent Claudication Market Share by Region (2020-2025)
 Table 8. Global Intermittent Claudication Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Intermittent Claudication Market Share by Region (2026-2031)
 Table 10. Intermittent Claudication Market Trends
 Table 11. Intermittent Claudication Market Drivers
 Table 12. Intermittent Claudication Market Challenges
 Table 13. Intermittent Claudication Market Restraints
 Table 14. Global Intermittent Claudication Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Intermittent Claudication Market Share by Players (2020-2025)
 Table 16. Global Top Intermittent Claudication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intermittent Claudication as of 2024)
 Table 17. Ranking of Global Top Intermittent Claudication Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Intermittent Claudication Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Intermittent Claudication, Headquarters and Area Served
 Table 20. Global Key Players of Intermittent Claudication, Product and Application
 Table 21. Global Key Players of Intermittent Claudication, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Intermittent Claudication Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Intermittent Claudication Revenue Market Share by Type (2020-2025)
 Table 25. Global Intermittent Claudication Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Intermittent Claudication Revenue Market Share by Type (2026-2031)
 Table 27. Global Intermittent Claudication Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Intermittent Claudication Revenue Market Share by Application (2020-2025)
 Table 29. Global Intermittent Claudication Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Intermittent Claudication Revenue Market Share by Application (2026-2031)
 Table 31. North America Intermittent Claudication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Intermittent Claudication Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Intermittent Claudication Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Intermittent Claudication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Intermittent Claudication Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Intermittent Claudication Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Intermittent Claudication Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Intermittent Claudication Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Intermittent Claudication Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intermittent Claudication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Intermittent Claudication Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Intermittent Claudication Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Intermittent Claudication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Intermittent Claudication Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Intermittent Claudication Market Size by Country (2026-2031) & (US$ Million)
 Table 46. I'ROM GROUP(DNAVEC Corporation) Company Details
 Table 47. I'ROM GROUP(DNAVEC Corporation) Business Overview
 Table 48. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Product
 Table 49. I'ROM GROUP(DNAVEC Corporation) Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 50. I'ROM GROUP(DNAVEC Corporation) Recent Development
 Table 51. Nuo Therapeutics Inc. Company Details
 Table 52. Nuo Therapeutics Inc. Business Overview
 Table 53. Nuo Therapeutics Inc. Intermittent Claudication Product
 Table 54. Nuo Therapeutics Inc. Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 55. Nuo Therapeutics Inc. Recent Development
 Table 56. Kowa Company Ltd. Company Details
 Table 57. Kowa Company Ltd. Business Overview
 Table 58. Kowa Company Ltd. Intermittent Claudication Product
 Table 59. Kowa Company Ltd. Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 60. Kowa Company Ltd. Recent Development
 Table 61. LTT Bio-Pharma Company Details
 Table 62. LTT Bio-Pharma Business Overview
 Table 63. LTT Bio-Pharma Intermittent Claudication Product
 Table 64. LTT Bio-Pharma Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 65. LTT Bio-Pharma Recent Development
 Table 66. Pluristem Therapeutics Inc. Company Details
 Table 67. Pluristem Therapeutics Inc. Business Overview
 Table 68. Pluristem Therapeutics Inc. Intermittent Claudication Product
 Table 69. Pluristem Therapeutics Inc. Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 70. Pluristem Therapeutics Inc. Recent Development
 Table 71. Nuo Therapeutics, Inc.(Aldagen, Inc.) Company Details
 Table 72. Nuo Therapeutics, Inc.(Aldagen, Inc.) Business Overview
 Table 73. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Product
 Table 74. Nuo Therapeutics, Inc.(Aldagen, Inc.) Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 75. Nuo Therapeutics, Inc.(Aldagen, Inc.) Recent Development
 Table 76. Genovate Biotechnology Co., Ltd. Company Details
 Table 77. Genovate Biotechnology Co., Ltd. Business Overview
 Table 78. Genovate Biotechnology Co., Ltd. Intermittent Claudication Product
 Table 79. Genovate Biotechnology Co., Ltd. Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 80. Genovate Biotechnology Co., Ltd. Recent Development
 Table 81. Novartis AG Company Details
 Table 82. Novartis AG Business Overview
 Table 83. Novartis AG Intermittent Claudication Product
 Table 84. Novartis AG Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 85. Novartis AG Recent Development
 Table 86. ID Pharma Co., Ltd Company Details
 Table 87. ID Pharma Co., Ltd Business Overview
 Table 88. ID Pharma Co., Ltd Intermittent Claudication Product
 Table 89. ID Pharma Co., Ltd Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 90. ID Pharma Co., Ltd Recent Development
 Table 91. Helixmith Co., Ltd. Company Details
 Table 92. Helixmith Co., Ltd. Business Overview
 Table 93. Helixmith Co., Ltd. Intermittent Claudication Product
 Table 94. Helixmith Co., Ltd. Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 95. Helixmith Co., Ltd. Recent Development
 Table 96. G. Pohl-Boskamp GmbH & Co. KG Company Details
 Table 97. G. Pohl-Boskamp GmbH & Co. KG Business Overview
 Table 98. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Product
 Table 99. G. Pohl-Boskamp GmbH & Co. KG Revenue in Intermittent Claudication Business (2020-2025) & (US$ Million)
 Table 100. G. Pohl-Boskamp GmbH & Co. KG Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Intermittent Claudication Picture
 Figure 2. Global Intermittent Claudication Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intermittent Claudication Market Share by Type: 2024 VS 2031
 Figure 4. by Treatment Process Features
 Figure 5. by Drug Type Features
 Figure 6. Global Intermittent Claudication Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Intermittent Claudication Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Clinics Case Studies
 Figure 10. Home Healthcare Case Studies
 Figure 11. Others Case Studies
 Figure 12. Intermittent Claudication Report Years Considered
 Figure 13. Global Intermittent Claudication Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Intermittent Claudication Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Intermittent Claudication Market Share by Region: 2024 VS 2031
 Figure 16. Global Intermittent Claudication Market Share by Players in 2024
 Figure 17. Global Top Intermittent Claudication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intermittent Claudication as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Intermittent Claudication Revenue in 2024
 Figure 19. North America Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Intermittent Claudication Market Share by Country (2020-2031)
 Figure 21. United States Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Intermittent Claudication Market Share by Country (2020-2031)
 Figure 25. Germany Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Intermittent Claudication Market Share by Region (2020-2031)
 Figure 33. China Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Intermittent Claudication Market Share by Country (2020-2031)
 Figure 41. Mexico Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Intermittent Claudication Market Share by Country (2020-2031)
 Figure 45. Turkey Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Intermittent Claudication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. I'ROM GROUP(DNAVEC Corporation) Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 49. Nuo Therapeutics Inc. Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 50. Kowa Company Ltd. Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 51. LTT Bio-Pharma Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 52. Pluristem Therapeutics Inc. Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 53. Nuo Therapeutics, Inc.(Aldagen, Inc.) Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 54. Genovate Biotechnology Co., Ltd. Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 55. Novartis AG Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 56. ID Pharma Co., Ltd Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 57. Helixmith Co., Ltd. Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 58. G. Pohl-Boskamp GmbH & Co. KG Revenue Growth Rate in Intermittent Claudication Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Peripheral Artery Revascularisation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peripheral Arterial Interventional Devices Market Research Report 2025
Global Peripheral Arterial Disease Diagnostics Market Research Report 2025
Global Intermittent Catheter Closed System Market Research Report 2024
Global Peripheral Artery Disease Devices Market Insights Forecast to 2030
Global Interventional Vascular Therapy Market Research Report 2025
Hydrophilic Intermittent Catheters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Arterial Compressor Market Research Report 2024
Global Balloon for Peripheral Arterial Disease Market Research Report 2025
Athletic Knee Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atherosclerosis Drug Market Insights Forecast to 2030
Global Intermittent Pneumatic Compression Pump Market Research Report 2024
Global Leg Exercise Equipment Market Research Report 2025
Global Restless Legs Syndrome Market Research Report 2025
Global Ankle Equipment Market Research Report 2024
Global Elbow Splint Market Insights Forecast to 2030
Global Lower Limb Artery Interventional Devices Market Research Report 2024
Global Drug Eluting Peripheral Stents Market Research Report 2025
Global Restless Legs Syndrome Treatment Market Research Report 2025
Mobile Vascular Imaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions